Document is current
Any future updates will be listed below
-
Authors
Hu, Wenxiang https://orcid.org/0000-0002-6754-5625
Lazar, Mitchell A. https://orcid.org/0000-0001-8653-1280
- License Information
-
More Information
Article History
Accepted: 27 July 2022
First Online: 7 September 2022
Competing interests
: M.A.L. is an advisory board member for Pfizer Inc., a consultant to Madrigal and Calico, and receives support from Pfizer for research not overlapping with the work reported here. W.H. declares no competing interests.
